智通财经APP获悉，巨子生物(02367)盘中涨近4%，截至发稿，涨3.88%，报50.9港元，成交额7393.55万港元。
浦银国际发布研报称，2024年“双11”期间巨子生物旗下两大品牌可复美及可丽金再次录得高增长。根据公司“双11”战报(2024年10月8日-11月11日对比2023年自然日同期)，可复美与可丽金线上全渠道GMV分别同比增长80%+和150%+。可复美的高速增长喜人，也较今年“618”的增速有所提升(“618”大促GMV 增速为60+%)。持续看好重组胶原蛋白行业以及公司化妆品产品的高速增长。该行认为，公司两大品牌在“双11”大促期间高速的增长支撑公司达成全年盈利目标(收入和经调净利润分别同比提升略高于40%和35%左右)。
报告指出，巨子生物旗下可复美与可丽金两品牌“双11”期间在多个线上平台的表现均十分亮眼，线上全渠道GMV 分别同比增长80%+和150%+。分平台来看，可复美在天猫、抖音、京东、唯品会分别同比增长50%+/100%+/200%+/100%+;可丽金在天猫、抖音、京东、唯品会分别同比增长100%+/500%+/200%+/100%+。该行认为，本次公司得以仍维持80%以上的增长得益于公司对于头部主播以及自播间建设有效的营销投入。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
No relevant data is available